Prevention of Ulcerative Colitis by Autologous Metabolite Transfer from Colitogenic Microbiota Treated with Lipid Nanoparticles Encapsulating an Anti-Inflammatory Drug Candidate

Modulating the gut microbiota composition is a potent approach to treat various chronic diseases, including obesity, metabolic syndrome, and ulcerative colitis (UC). However, the current methods, such as fecal microbiota transplantation, carry a risk of serious infections due to the transmission of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chunhua, Sung, Junsik, Long, Dingpei, Alghoul, Zahra, Merlin, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228491/
https://www.ncbi.nlm.nih.gov/pubmed/35745805
http://dx.doi.org/10.3390/pharmaceutics14061233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228491/
https://www.ncbi.nlm.nih.gov/pubmed/35745805
http://dx.doi.org/10.3390/pharmaceutics14061233

Ejemplares similares